271980.KO · Jeil Pharmaceutical Co.,Ltd

-

Please sign in to comment on 271980.KO

1 Comment

Admin

4 years ago

Jeil Pharmaceutical Co.,Ltd is currently in a long term downtrend where the price is trading 14.3% below its 200 day moving average.

From a valuation standpoint, the stock is 90.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.8.

Jeil Pharmaceutical Co.,Ltd's total revenue rose by 3.4% to $173B since the same quarter in the previous year.

Its net income has increased by 102.0% to $275M since the same quarter in the previous year.

Finally, its free cash flow grew by 36.4% to $6B since the same quarter in the previous year.

Based on the above factors, Jeil Pharmaceutical Co.,Ltd gets an overall score of 4/5.

ISIN	KR7271980005
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Exchange	KO
CurrencyCode	KRW

Dividend Yield	None
Target Price	None
Market Cap	184B
Beta	1.12

ABOUT

Jeil Pharmaceutical Co.,Ltd

Jeil Pharmaceutical Co.,Ltd develops and supplies pharmaceutical products primarily in South Korea. It provides products in the areas of antibiotic, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamine. The company also exports its products to approximately 40 countries in ASEAN, Central and South America, Africa, and internationally. Jeil Pharmaceutical Co.,Ltd was founded in 1959 and is headquartered in Seoul, South Korea.

271980.KO · Jeil Pharmaceutical Co.,Ltd

-

Jeil Pharmaceutical Co.,Ltd

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Jeil Pharmaceutical Co.,Ltd using a moving average strategy